Coenzyme Q10 Absorption and Tolerance in Children With Down Syndrome: A Dose-Ranging Trial

This publication has 34 references indexed in Scilit:

• Can cognitive deterioration associated with Down syndrome be reduced?
  Medical Hypotheses, 2005
• Anti-oxidant gene expression imbalance, aging and Down syndrome
  Life Sciences, 2005
• Influence of coenzyme Q10 and cerivastatin on the flow-mediated vasodilation of the brachial artery: results of the ENDOTACT study
  International Journal of Cardiology, 2005
• Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease
  Experimental Neurology, 2004
• Coenzyme Q10 in patients with end‐stage heart failure awaiting cardiac transplantation: A randomized, placebo‐controlled study
  Clinical Cardiology, 2004
• Mitochondriopathies
  European Journal of Neurology, 2004
• Combined effect of coenzyme Q10 and fenofibrate on forearm microcirculatory function in type 2 diabetes
  Atherosclerosis, 2003
• The reduction of NADH: Ubiquinone oxidoreductase 24- and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer's disease
  Life Sciences, 2001
• Recovery of the systolic time intervals by coenzyme Q10 in patients with a load-induced cardiac dysfunction
  Molecular Aspects of Medicine, 1997
• Hematological Studies in Children with Down Syndrome
  Pediatric Hematology and Oncology, 1996